dc.contributor.author | Thorat, MA | en_US |
dc.date.accessioned | 2023-08-01T10:36:30Z | |
dc.date.issued | 2023-07-20 | en_US |
dc.identifier.uri | https://qmro.qmul.ac.uk/xmlui/handle/123456789/89904 | |
dc.format.extent | 719 - 720 | en_US |
dc.language | eng | en_US |
dc.relation.ispartof | Oncotarget | en_US |
dc.rights | Attribution 3.0 United States | * |
dc.rights.uri | http://creativecommons.org/licenses/by/3.0/us/ | * |
dc.subject | ER | en_US |
dc.subject | clonality | en_US |
dc.subject | ductal carcinoma in situ (DCIS) | en_US |
dc.subject | invasive breast cancer | en_US |
dc.subject | recurrence | en_US |
dc.subject | Humans | en_US |
dc.subject | Female | en_US |
dc.subject | Carcinoma, Intraductal, Noninfiltrating | en_US |
dc.subject | Carcinoma, Ductal, Breast | en_US |
dc.subject | Receptor, ErbB-2 | en_US |
dc.subject | Breast Neoplasms | en_US |
dc.title | Multiclonality of ER expression in DCIS - Implications for clinical practice and future research. | en_US |
dc.type | Article | |
dc.identifier.doi | 10.18632/oncotarget.28450 | en_US |
pubs.author-url | https://www.ncbi.nlm.nih.gov/pubmed/37477525 | en_US |
pubs.notes | Not known | en_US |
pubs.publication-status | Published online | en_US |
pubs.volume | 14 | en_US |
qmul.funder | Cancer Prevention::Cancer Research UK | en_US |
qmul.funder | Cancer Prevention::Cancer Research UK | en_US |